ADARx 
Welcome,         Profile    Billing    Logout  
  Products    Diseases   Products    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ADX-324 / ADARx
NCT05691361: Safety, Tolerability, PK, PD of ADX-324 in Healthy Volunteers and Hereditary Angioedema Patients

Recruiting
1
53
RoW
ADX-324, siRNA, Placebo, Saline
ADARx Pharmaceuticals, Inc., Avance Clinical Pty Ltd.
Hereditary Angioedema
07/25
01/26

Download Options